Grace Kong is a Nuclear Medicine Physician at the Peter MacCallum Cancer Centre (PMCC) Australia, a Clinical Associate Professor at the University of Melbourne, Sir Peter MacCallum Department of Oncology. She is the Co-Chair of the PMCC Neuroendocrine Tumour (NET) Unit, a European Neuroendocrine Tumor Society (ENETS) Center of Excellence. She is the Lead of Radionuclide Therapy at PMCC, the Chair of the NET multidisciplinary meeting (MDM), and the Nuclear Medicine Lead for the upper gastrointestinal tumor MDM. She previously completed a fellowship at the Royal Marsden Hospital (UK) and was a recipient of the Foundation Discovery Partner Fellowship grant award. She has broad clinical and research interests in cancer imaging, with the focus in advancing theranostics and precision medicine in cancer treatment. She is the PI for 10+ active prospective national and international collaborative diagnostic and theranostics trials, and a co-investigator of many oncologic studies particularly in peptide receptor radionuclide therapy (PRRT), NET, prostate cancer and thyroid cancer. She actively participates in research and education at national and international meetings, is a member of the AANMS committee for Theranostics education.
